ALC, approved by the U.S
Specifically, body mass decreased by 9% after three months, 5% after six months, and 4% after 12 months
While there is ongoing debate in the supplement industry about the superiority of ubiquinol (the reduced form) versus ubiquinone (the oxidized form), clinical research shows that both forms can significantly and effectively raise plasma CoQ10 levels
This timeframe allows for cellular glutathione repletion, adaptation to injection routines, assessment of individual response patterns, and development of sustainable administration habits
Based on this finding, all Phase 3 TRIUMPH trials use 2 mg as the universal starting dose, with the first escalation to 4 mg occurring at week 5
Others may be used in physician-guided wellness or regenerative care, depending on the patient, the clinical goal, and the treatment plan